In een gesprek met Vogue deelt Serena Williams dat ze afslankmedicijn GLP-1 gebruikt. "Transparantie is voor mij belangrijk." ...

Serena Williams is opening up about her fitness journey, revealing that she has lost 31 pounds using the injectable GLP-1 ...

Serena Williams reveals her use of GLP-1, Zepbound and calls out the stigma surrounding the use of the popular weight loss ...

Fabrikanten van afslankmedicijnen zullen naar verwachting tegen begin 2030 meer dan $150 miljard aan inkomsten binnenhalen, dankzij de toenemende populariteit van Eli Lilly’s Zepbound en Novo Nordisk’ ...

GLP-1 meds are trending after Serena Williams’ 31-pound weight loss. A doctor breaks down the side effects, safety concerns & ...

Serena Williams has revealed she lost 31 pounds on the GLP-1 Zepbound: "I just couldn't get my weight to where I needed to be ...

Tennis champion Serena Williams has divided the internet after revealing she’s been using a GLP-1 weight loss drug. The ...

" Afvalspuiten” zoals semaglutide ( Ozempic/Wegovy) en tirzepatide (Mounjaro/Zepbound) remmen honger en vertragen de ...

Serena Williams lost 31 pounds using Zepbound after traditional training failed, opening up about health, hormones, and her ...

After sitting down for several interviews to discuss her use of GLP-1 weight loss medication, Serena Williams is opening up ...

Investing.com - Guggenheim heeft woensdag het koersdoel voor Eli Lilly (NYSE:LLY) verlaagd naar $ 875,00 van $ 942,00, maar ...

GLP-1 drugs for diabetes and weight loss may influence patients’ cancer risk, usually lowering it but sometimes possibly ...